TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22192348

Group type: EXPERIMENTAL
Intervention: Surgical management
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Outpatient manual vacuum aspiration (MVA)
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Inpatient electric vacuum aspiration (EVA)
Number of subjects: 652

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 652
Study: 19074911

Group type: EXPERIMENTAL
Intervention: Abatacept (approximately 10 mg/kg)
Number of subjects: 1046
Study: 17867511

Group type: EXPERIMENTAL
Intervention: Multifocal intraocular lens Array (AMO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Monofocal intraocular lens AcrySof (Alcon)
Number of subjects: 30
Study: 15876443

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) in Caala
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) in Kuito
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ) in Caala
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ) in Kuito
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Amodiaquine + Artesunate (AQ+AS)
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine + Artesunate (SP+AS)
Number of subjects: 619
Study: 11723014

Group type: EXPERIMENTAL
Intervention: Complete ST resolution (>/=70%)
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Partial ST resolution (30% to 70%)
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: No ST resolution (<30%)
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated <2 hours after symptom onset
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated between 2 to 4 hours after symptom onset
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated >4 hours after symptom onset
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated <2 hours with partial ST resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated between 2 to 4 hours with partial ST resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated >4 hours with partial ST resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated <2 hours with no ST resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated between 2 to 4 hours with no ST resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Patients treated >4 hours with no ST resolution
Number of subjects: 13100
Study: 9190163

Group type: EXPERIMENTAL
Intervention: Intubation with thiopental and vecuronium bromide
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Laryngeal mask (LMN) with thiopental
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Laryngeal mask (LMN) with propofol
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine LMN control group (100 children)
Number of subjects: 200
Study: 7965897

Group type: EXPERIMENTAL
Intervention: All‐Bond‐2 adhesive
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Amalgambond Plus adhesive
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TMS Minim pins
Number of subjects: 45
Study: 3294615

Group type: EXPERIMENTAL
Intervention: Cefamandole (15 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tobramycin (1.5 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tobramycin (3 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cefamandole (15 mg/kg) + Tobramycin (1.5 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cefamandole (15 mg/kg) + Tobramycin (3 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cefamandole alone
Number of subjects: 10
Study: 30431426

Group type: EXPERIMENTAL
Intervention: FS Spiromax 500/50 µg
Number of subjects: 156

Group type: COMPARATOR
Intervention: Seretide Accuhaler 50/500 µg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: FS Spiromax 500/50 µg with charcoal block
Number of subjects: 156

Group type: COMPARATOR
Intervention: Seretide Accuhaler 50/500 µg with charcoal block
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: FS Spiromax and Seretide Accuhaler
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: FS Spiromax
Number of subjects: 156

Group type: COMPARATOR
Intervention: Seretide Accuhaler
Number of subjects: 156
Study: 28453445

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Exercise Approach (CBEA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 41
Study: 25884190

Group type: EXPERIMENTAL
Intervention: e-learning program and a brochure
Number of subjects: 322

Group type: COMPARATOR
Intervention: brochure only
Number of subjects: 322
Study: 24080020

Group type: EXPERIMENTAL
Intervention: CRA plus CM
Number of subjects: 108

Group type: COMPARATOR
Intervention: CRA
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: CM
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Interaction of unemployment and depressive symptoms
Number of subjects: 108
Study: 21819934

Group type: EXPERIMENTAL
Intervention: Decompensated LC
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Patients with TIPS
Number of subjects: 25
Study: 19175713

Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid (ALA)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 16720619

Group type: EXPERIMENTAL
Intervention: Dr Atkins' new diet revolution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slim‐Fast plan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight Watchers pure points programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rosemary Conley's eat yourself slim diet and fitness plan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 14699543

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no intravenous antibiotics)
Number of subjects: 56
Study: 11721154

Group type: EXPERIMENTAL
Intervention: Standard calcium reduced diet (300 mg/24 h) for 4 weeks after a 3-week run-in period (dietary calcium content 700-1,000 mg/24 h)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Normal calcium-containing diet after the calcium restriction period
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (43 healthy persons)
Number of subjects: 27
Study: 9012545

Group type: EXPERIMENTAL
Intervention: Sizofiran (SPG) administration
Number of subjects: 0
Study: 1376812

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3891497

Group type: EXPERIMENTAL
Intervention: Heidelberg capsule after a 4-ml/kg liquid fatty meal
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Frequent feeding
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Liquid meal (200 ml of diluted light cream)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Standard breakfast including solid food
Number of subjects: 22
Study: 31704939

Group type: EXPERIMENTAL
Intervention: Batch email interruptions with exogenous stress
Number of subjects: 63

Group type: COMPARATOR
Intervention: Batch email interruptions without exogenous stress
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Continual email interruptions with exogenous stress
Number of subjects: 63

Group type: COMPARATOR
Intervention: Continual email interruptions without exogenous stress
Number of subjects: 63
Study: 30269275

Group type: EXPERIMENTAL
Intervention: ABP 215
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 24
Study: 27421057

Group type: EXPERIMENTAL
Intervention: Combination HIV prevention package (including household‐based HIV counselling and testing and anti‐retroviral treatment eligibility regardless of CD4‐count)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Broad Brush Survey (BBS) qualitative data
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Meta-indicators of local context
Number of subjects: 21
Study: 24645793

Group type: EXPERIMENTAL
Intervention: Avenanthramide (AVA) supplementation (9.2 mg AVA per day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (0.4 mg AVA per day)
Number of subjects: 16
Study: 23235391

Group type: EXPERIMENTAL
Intervention: Low-dose erythropoietin stimulating agent (ESA) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No erythropoietin stimulating agent (no-ESA) treatment
Number of subjects: 0
Study: 19896252

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG) at a dose of 10^9 colony-forming units in 100ml of a fermented milk product
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo (same post-pasteurized fermented milk product without LGG)
Number of subjects: 281
Study: 17828687

Group type: EXPERIMENTAL
Intervention: Multimodal intervention program
Number of subjects: 404

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 404
Study: 15994629

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo acupuncture treatment
Number of subjects: 85
Study: 12435170

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa 3.0 microg/kg every 2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa 5.0 microg/kg every 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epoetin alfa 40,000 U weekly (increased to 60,000 U weekly for inadequate response)
Number of subjects: 0
Study: 10342360

Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hexarelin (HEX)
Number of subjects: 7
Study: 8954380

Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (60 minutes once a week for 10 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (current level of activity)
Number of subjects: 46
Study: 8250189

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 34
Study: 3562679

Group type: EXPERIMENTAL
Intervention: Written information with verbal reinforcement
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no hand-out)
Number of subjects: 150
Study: 30156436

Group type: EXPERIMENTAL
Intervention: MEC (DigeZyme®) 50 mg, TID for 60 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28160012

Group type: EXPERIMENTAL
Intervention: Seletalisib (5-90 mg QD and 30 mg BID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24057053

Group type: EXPERIMENTAL
Intervention: Auditory-fast condition (voluntarily stopped fast movement in response to auditory cue)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory-slow condition (voluntarily stopped slow movement in response to auditory cue)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Obstacle conditions (mechanically prevented from moving further)
Number of subjects: 0
Study: 21840468

Group type: EXPERIMENTAL
Intervention: Placebo plus mixture of hesperidin, luteolin, and naringenin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Orange juice (positive control)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (ascorbic acid and sugar equivalent to orange juice)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Placebo plus hesperidin
Number of subjects: 16
Study: 19717722

Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg twice daily from days 1 to 5 with 100 mg lamotrigine on day 4
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lamotrigine 100 mg alone on day 32
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Raltegravir + lamotrigine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lamotrigine alone
Number of subjects: 24
Study: 17489013

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT) during shoulder press exercise
Number of subjects: 1
Study: 14644147

Group type: EXPERIMENTAL
Intervention: Serial MRI analysis technique for cerebral atrophy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11497195

Group type: EXPERIMENTAL
Intervention: Omapatrilat (10 or 20 mg, titrated to 20 or 40 mg) plus 25 mg of HCTZ
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Omapatrilat (20/40 mg) plus 25 mg of HCTZ
Number of subjects: 657

Group type: COMPARATOR
Intervention: Placebo plus 25 mg of HCTZ
Number of subjects: 657
Study: 9032212

Group type: EXPERIMENTAL
Intervention: Platelet-derived growth factor (PDGF) positive cells in BOOP
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CD68+ macrophages in BOOP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PDGFR-beta immunoreactivity in BOOP
Number of subjects: 30
Study: 8345313

Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude, short lever adjustment of a single vertebra from among C1 and T3-T7
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham adjustment similar to a manual diagnostic pressure test at C1, T3-T7 or T9-T10
Number of subjects: 42
Study: 2938394

Group type: EXPERIMENTAL
Intervention: Alfentanil (50 micrograms/kg) and atracurium (0.5 mg/kg)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Fentanyl (5 micrograms/kg) and pancuronium (0.07 mg/kg)
Number of subjects: 62
Study: 31729771

Group type: EXPERIMENTAL
Intervention: Teamwork enhancement and quality improvement program
Number of subjects: 72
Study: 29294363

Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 285

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 285
Study: 27831635

Group type: EXPERIMENTAL
Intervention: Short GnRH agonist protocol
Number of subjects: 250

Group type: COMPARATOR
Intervention: Clomiphene citrate plus FSH and antagonist
Number of subjects: 250

Group type: COMPARATOR
Intervention: GnRH antagonist protocol
Number of subjects: 250
Study: 25335325

Group type: EXPERIMENTAL
Intervention: Jiangtang Xiaozhi Capsule (JTXZC), 4 pills three times per day for 8 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: Pioglitazone Tablet, 15 mg once daily for 8 weeks
Number of subjects: 73
Study: 23184201

Group type: EXPERIMENTAL
Intervention: Diaphragmatic pacemaker placement
Number of subjects: 5
Study: 20407035

Group type: EXPERIMENTAL
Intervention: Pulses of vincristine and corticosteroids
Number of subjects: 411

Group type: COMPARATOR
Intervention: No pulses
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Pulses in PRED group
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Pulses in DEX group
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Pulses in girls
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Pulses in boys
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Pulses
Number of subjects: 411
Study: 18199700

Group type: EXPERIMENTAL
Intervention: Rapid diagnostic tests for malaria
Number of subjects: 2425

Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 2425

Group type: COMPARATOR
Intervention: Presumptive treatment
Number of subjects: 2425
Study: 15928281

Group type: EXPERIMENTAL
Intervention: Complicated grief treatment
Number of subjects: 95

Group type: COMPARATOR
Intervention: Interpersonal psychotherapy
Number of subjects: 95
Study: 12869086

Group type: EXPERIMENTAL
Intervention: Triple therapy (n=45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (n=45)
Number of subjects: 90
Study: 8931917

Group type: EXPERIMENTAL
Intervention: Haloperidol (0.5 mg, intravenously)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline-injected controls
Number of subjects: 0
Study: 1673050

Group type: EXPERIMENTAL
Intervention: Esmolol 50 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Esmolol 100 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 7008800

Group type: EXPERIMENTAL
Intervention: levamisole 150 mg weekly
Number of subjects: 26

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study: 30443778

Group type: EXPERIMENTAL
Intervention: Customized virtual surgical planning (VSP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional surgical planning (CSP)
Number of subjects: 21
Study: 28270226

Group type: EXPERIMENTAL
Intervention: Adipose-derived mesenchymal stem cells (ASC) administered to the submandibular glands
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo administered to the submandibular glands
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Adipose-derived mesenchymal stem cells (ASC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 26451726

Group type: EXPERIMENTAL
Intervention: FloraGLO® (Kemin Japan)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: XanMax® (Katra Phytochem)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both supplement groups
Number of subjects: 36
Study: 23786610

Group type: EXPERIMENTAL
Intervention: 0.1 M EDC
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.5 M EDC
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.5 M EDC + 35% HEMA
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 5% PA
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 2% CHX
Number of subjects: 6

Group type: COMPARATOR
Intervention: Deionized water (control)
Number of subjects: 6
Study: 21930310

Group type: EXPERIMENTAL
Intervention: Multidisciplinary postoperative intervention program
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional postoperative routines
Number of subjects: 64
Study: 19207345

Group type: EXPERIMENTAL
Intervention: intensive MI/CBT
Number of subjects: 97

Group type: COMPARATOR
Intervention: BI alone
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: computer-based treatment
Number of subjects: 97
Study: 17987226

Group type: EXPERIMENTAL
Intervention: HPV L1 VLP vaccines
Number of subjects: 0
Study: 15293422

Group type: EXPERIMENTAL
Intervention: SingleBond + Filtek Z250 (SB)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond + AP-X (SE)
Number of subjects: 4
Study: 12772885

Group type: EXPERIMENTAL
Intervention: docetaxel 75 mg/m2 plus cisplatin 75 mg/m2, plus a 5‐day continuous infusion of 750 mg/m2 5‐fluorouracil (FU; TCF)
Number of subjects: 158

Group type: COMPARATOR
Intervention: docetaxel 85 mg/m2 plus cisplatin 75 mg/m2 (TC)
Number of subjects: 158
Study: 9850487

Group type: EXPERIMENTAL
Intervention: Intensive treatment policy with sulfonylurea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive treatment policy with metformin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive treatment policy with insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional policy (diet therapy)
Number of subjects: 0
Study: 8602338

Group type: EXPERIMENTAL
Intervention: Triclosan-containing dentifrice (0.3% triclosan, 2% Gantrez copolymer, 0.243% sodium fluoride)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Placebo dentifrice without triclosan
Number of subjects: 325
Study: 2665109

Group type: EXPERIMENTAL
Intervention: Self-care group
Number of subjects: 87

Group type: COMPARATOR
Intervention: GP-control group
Number of subjects: 87
Study: 338105

Group type: EXPERIMENTAL
Intervention: Fluorouracil, 1 g daily, as a continuous infusion into the portal venous system during the first seven days after operation.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 50
Study: 31510957

Group type: EXPERIMENTAL
Intervention: Integrated community case management (iCCM) by community health volunteers (CHVs) trained to screen, diagnose, and treat MAM and SAM.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control arm with CHVs only screening and referring MAM/SAM cases to health facilities.
Number of subjects: 240
Study: 26369302

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team intervention
Number of subjects: 4

Group type: COMPARATOR
Intervention: Regular ad hoc organization (control)
Number of subjects: 4
Study: 26218029

Group type: EXPERIMENTAL
Intervention: Removable prostheses
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Implant-supported fixed prostheses
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (10 subjects with Class I natural dentition)
Number of subjects: 10
Study: 23936607

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 106
Study: 21524765

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 160 mg/bid for 8 weeks
Number of subjects: 38
Study: 18056769

Group type: EXPERIMENTAL
Intervention: Cyclical oral contraception (21‐d active/7‐d placebo for six consecutive 28‐d cycles)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Continuous oral contraception (168‐d active pill)
Number of subjects: 62
Study: 17153971

Group type: EXPERIMENTAL
Intervention: Carbamide peroxide 10%, 15%, or 20%
Number of subjects: 44
Study: 12698777

Group type: EXPERIMENTAL
Intervention: Oral hydration (2L of water daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (AFI > 10th and < 90th percentile)
Number of subjects: 30
Study: 11200750

Group type: EXPERIMENTAL
Intervention: Immunochromatographic assay detecting IgG antibodies against antigen 38 kDa (Rapid Test TB)
Number of subjects: 278
Study: 8999567

Group type: EXPERIMENTAL
Intervention: External fixation ad modum Hoffman
Number of subjects: 41

Group type: COMPARATOR
Intervention: Percutaneous pinning and plaster cast
Number of subjects: 41
Study: 1281729

Group type: EXPERIMENTAL
Intervention: Terazosin (2, 5 or 10 mg)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 6373442

Group type: EXPERIMENTAL
Intervention: Piretanide 6 mg b.i.d.
Number of subjects: 93

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT) 25 mg b.i.d.
Number of subjects: 93

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT) 50 mg b.i.d.
Number of subjects: 93
Study: 31343273

Group type: EXPERIMENTAL
Intervention: Trial micronutrients (n=19)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Psychiatric medications (n=21)
Number of subjects: 93

Group type: COMPARATOR
Intervention: No treatment (n=35)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Trial micronutrients
Number of subjects: 93
Study: 28320323

Group type: EXPERIMENTAL
Intervention: Rocuronium administered with closed-loop feedback infusion system in group laparoscopy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rocuronium administered with closed-loop feedback infusion system in group control
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group laparoscopy compared to group control
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 60